Journal News

MCP: How exercise works its biomolecular wonders

John Arnst
December 01, 2017

Exercise has long been known to benefit the entire body, from burning fat and strengthening muscles to boosting the immune system and reducing the risk of some cancers. To understand how some of these effects are controlled on a cellular level, researchers at the University of Sydney did a proteomic analysis of the swarm of peptides and small-protein hormones that circulate throughout the body in blood plasma.

Benjamin Parker, the first author on the paper published in Molecular & Cellular Proteomics, said, “There’s a big push in the field to identify secreted factors that allow organs to communicate with each other, and this might enable them to adapt to certain environmental stresses … like exercise.” The researchers ultimately hope that their novel combination of techniques for proteomic analysis might be used to pinpoint the factors behind certain health benefits for potential drug development.

Parker and colleagues used a combination of tagging and fragmentation techniques, multidimensional liquid chromatography and tandem mass spectrometry to identify 5,548 peptides in the peptidome, the aggregate of peptide molecules that circulate in the plasma with blood cells. They found that the levels of the circulating small molecules were modulated rapidly during and after exercise through a network of post-translational modifications and proteases.

“We know that when we exercise, there will be certain factors and hormones that get released into our body, into our bloodstream, that then enable different tissues to adapt to that increased workload,” Parker said. While the researchers noted expected elevated levels of hormones, including insulin and the vasodilator bradykinin, they also found that antimicrobial and immune-related peptides were upregulated.

“We don’t know exactly why the body is doing that, but you could maybe (make the) link that exercise is improving our immune system,” Parker said.

Parker and colleagues analyzed blood samples collected before, during and after exercise from volunteers at a facility at the University of Copenhagen operated by co-authors Erik Richter, Bente Kiens and Jørgen Wojtaszewski, who have been exploring the effects of exercise on various signaling molecules for more than two decades.

The researchers also noted the presence of new, uncharacterized peptides that were found to affect cells’ ability to grow and proliferate, which may play a role in the noted anticancer effects of exercise, Parker said.

Examining the levels of certain peptides in blood plasma also allowed the researchers to characterize the activity of the numerous proteases that cleaved the peptides into their smaller, functional selves. By monitoring these protease levels, Parker and his colleagues were able to infer whether exercise is responsible for an increase or a decrease in specific proteases, some of which have been associated with an increased risk of heart attacks during strenuous exercise for people with higher rates of arterial plaques.

“There’s sort of a controversy in the field about how good it is to activate certain proteases with exercise,” Parker said. “It could be related to how we activate proteases that cause plaques to rupture in our hearts, in our coronary circulation.” In that case, he said, strenuous exercise “may not be always a beneficial thing.”

Parker and colleagues are continuing their proteomic analyses by examining the functional surfaces of exosomes, which are small membrane-bound vesicles used to send proteins, DNA and RNA between distant cells and organs, and they hope to publish their follow-up results soon.

John Arnst

John Arnst was a science writer for ASBMB Today.

Join the ASBMB Today mailing list

Sign up to get updates on articles, interviews and events.

Latest in Science

Science highlights or most popular articles

Brain Injury Awareness Month 2021
Health Observance

Brain Injury Awareness Month 2021

March 01, 2021

In the U.S., about 2.8 million people sustain a traumatic brain injury annually. Learn about recent research on TBI-related dementia, dysfunctional mitochondria and other work powering the march toward better therapies.

The evolution of proteins from mysteries to medicines
Essay

The evolution of proteins from mysteries to medicines

February 27, 2021

An essay in observance of National Protein Day.

'Every experiment and every breakthrough matters'
Health Observance

'Every experiment and every breakthrough matters'

February 26, 2021

An interview with NYMC dean Marina K. Holz, who studies a rare disease that affects women of childbearing age.

Progeria: From the unknown to the first FDA-approved treatment
Health Observance

Progeria: From the unknown to the first FDA-approved treatment

February 25, 2021

Hutchinson–Gilford progeria syndrome is a rare, fatal genetic disease that causes premature aging.

Raising awareness and funding for Pompe disease
Health Observance

Raising awareness and funding for Pompe disease

February 25, 2021

Father-turned-advocate has founded multiple organizations to support families and search for better therapies for people with rare lysosomal storage disorder.

A novel approach to septic shock leads to a prospective new therapy
Journal News

A novel approach to septic shock leads to a prospective new therapy

February 23, 2021

A French research team finds new evidence supporting endotoxin removal for treating life-threatening inflammation.